[C@@H] 1([C@@H] ([C@H] ([C@@H] ([C@H] (O1) CO) O[C@H] 2[C@@H] ([C@H] ([C@H] ([C@H] (O2) CO) O[C@@H] 3[C@@H] ([C@H] ([C@H] ([C@H] (O3) CO) O) O) O) O) O) O) O) OC[C@@H] ([C@@H] (/C=C/CCCCCCCCCCCCC) O) NC(=O) * |
|
Mus musculus
(NCBI:txid10090)
|
Source: BioModels - MODEL1507180067
See:
PubMed
|
mouse metabolite
Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
antigen
Any substance that stimulates an immune response in the body, such as through antibody production or by presentation to a T-cell receptor after binding to a major histocompability complex (MHC).
|
|
View more via ChEBI Ontology
Outgoing
|
α- D- galactosyl- (1→4)- β- D- galactosyl- (1→4)- β- D- glucosylceramide
(CHEBI:18313)
has role
antigen
(CHEBI:59132)
α- D- galactosyl- (1→4)- β- D- galactosyl- (1→4)- β- D- glucosylceramide
(CHEBI:18313)
has role
mouse metabolite
(CHEBI:75771)
α- D- galactosyl- (1→4)- β- D- galactosyl- (1→4)- β- D- glucosylceramide
(CHEBI:18313)
is a
α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1)-ceramide
(CHEBI:88154)
α- D- galactosyl- (1→4)- β- D- galactosyl- (1→4)- β- D- glucosylceramide
(CHEBI:18313)
is a
glycotriaosylceramide
(CHEBI:36508)
|
|
Incoming
|
α-D-Gal-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1ʼ)-N- acylsphingosine
(CHEBI:140745)
has functional parent
α- D- galactosyl- (1→4)- β- D- galactosyl- (1→4)- β- D- glucosylceramide
(CHEBI:18313)
α-D-galactosyl-D-galactosyl-D-glucosylsphingosine
(CHEBI:228802)
has functional parent
α- D- galactosyl- (1→4)- β- D- galactosyl- (1→4)- β- D- glucosylceramide
(CHEBI:18313)
β-D-GlcNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1ʼ)-ceramide(d18:1(4E))
(CHEBI:141182)
has functional parent
α- D- galactosyl- (1→4)- β- D- galactosyl- (1→4)- β- D- glucosylceramide
(CHEBI:18313)
α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-Cer(d18:1/26:1(17Z))
(CHEBI:133816)
is a
α- D- galactosyl- (1→4)- β- D- galactosyl- (1→4)- β- D- glucosylceramide
(CHEBI:18313)
α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-N-hexacosanoylceramide
(CHEBI:75188)
is a
α- D- galactosyl- (1→4)- β- D- galactosyl- (1→4)- β- D- glucosylceramide
(CHEBI:18313)
|
N- [(2S,3R,4E)- 1- {[α- D- galactopyranosyl- (1→4)- β- D- galactopyranosyl- (1→4)- β- D- glucopyranosyl]oxy}- 3- hydroxyoctadec- 4- en- 2- yl]alkanamide
|
a globoside Gb3Cer (d18:1(4E))
|
UniProt
|
α- D- Gal- (1→4)- β- D- Gal- (1→4)- β- D- Glc- (1↔1')- Cer
|
JCBN
|
α- D- galactosyl- (1→4)- β- D- galactosyl- (1→4)- β- D- glucosyl- (1↔1)- ceramide
|
ChEBI
|
α- D- Galp- (1→4)- β- D- Galp- (1→4)- β- D- Glcp- (1↔1')- Cer
|
JCBN
|
Burkitt's lymphoma antigen, bla-CD77
|
ChemIDplus
|
ceramide trihexoside
|
ChEBI
|
CTH
|
ChEBI
|
D-Galactosyl-1,4-D-galactosyl-1,4-D-glucosylceramide
|
KEGG COMPOUND
|
Gal-alpha1->4Gal-beta1->4Glc-beta1->1'Cer
|
KEGG COMPOUND
|
Gal-alpha1->4LacCer
|
KEGG COMPOUND
|
Gal-α1→4LacCer
|
KEGG COMPOUND
|
Galα1-4Galβ1-4Glcβ1-1'ceramide
|
ChEBI
|
Gb3
|
ChEBI
|
Gb3Cer
|
KEGG GLYCAN
|
GbOSe3Cer
|
ChEBI
|
globotriaosylceramide
|
ChemIDplus
|
globotrihexosylceramide
|
ChEBI
|
Globotriosylceramide
|
KEGG COMPOUND
|
Trihexosylceramide
|
KEGG COMPOUND
|
71965-57-6
|
CAS Registry Number
|
ChemIDplus
|
11437603
|
PubMed citation
|
Europe PMC
|
11525645
|
PubMed citation
|
Europe PMC
|
11946769
|
PubMed citation
|
Europe PMC
|
12227795
|
PubMed citation
|
Europe PMC
|
15113548
|
PubMed citation
|
Europe PMC
|
1528196
|
PubMed citation
|
Europe PMC
|
16120140
|
PubMed citation
|
Europe PMC
|
1724444
|
PubMed citation
|
Europe PMC
|
17258170
|
PubMed citation
|
Europe PMC
|
17674039
|
PubMed citation
|
Europe PMC
|
18176841
|
PubMed citation
|
Europe PMC
|
18810447
|
PubMed citation
|
Europe PMC
|
19655181
|
PubMed citation
|
Europe PMC
|
20424866
|
PubMed citation
|
Europe PMC
|
20623712
|
PubMed citation
|
Europe PMC
|
2120125
|
PubMed citation
|
Europe PMC
|
21252262
|
PubMed citation
|
Europe PMC
|
21376640
|
PubMed citation
|
Europe PMC
|
2448252
|
PubMed citation
|
Europe PMC
|
2456994
|
PubMed citation
|
Europe PMC
|
2500499
|
PubMed citation
|
Europe PMC
|
2960671
|
PubMed citation
|
Europe PMC
|
7691279
|
PubMed citation
|
Europe PMC
|
7841803
|
PubMed citation
|
Europe PMC
|
|